share_log

復旦張江:海外監管公告-海通證券股份有限公司關於上海復旦張江生物醫藥股份有限公司 2023 年年度報告的信息披露監管問詢函的核查意見

FUDANZHANGJIANG: Overseas Regulatory Announcement-Haitong Securities Co., Ltd.'s Review of Information Disclosure Regulatory Inquiry Letter on Shanghai Fudan Zhangjiang Biopharmaceutical Co., Ltd. 2023 Annual Report

Hong Kong Stock Exchange ·  Apr 29 05:15
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more